Caxton Associates LP Lexicon Pharmaceuticals, Inc. Transaction History

Caxton Associates LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$1.8 - $2.56 $15,300 - $21,760	-8,500 Reduced 15.52%	46,281 $88,000
Q3 2022 Nov 14, 2022	BUY	$1.94 - $3.43 $106,275 - $187,898	54,781 New	54,781 $131,000
Q2 2021 Aug 16, 2021	SELL	$4.12 - $5.87 $118,264 - $168,498	-28,705 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$3.45 - $9.09 $61,955 - $163,238	17,958 Added 167.1%	28,705 $168,000
Q4 2020 Feb 16, 2021	BUY	$1.05 - $3.67 $11,284 - $39,441	10,747 New	10,747 $37,000

134

196M

310K

77.3K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $128M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.